Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

July 22, 2015July 22, 2015

Cancer Immunotherapy Based on Engineered Immune Cells as a Promising Approach Against Myeloma

News

A study recently published in the journal Nature Medicine revealed that cancer immunotherapy can be successfully employed against multiple myeloma. The study is entitled “NY-ESO-1–specific TCR–engineered T cells mediate sustained ... Read more

June 29, 2015June 30, 2015

NivoPlus Clinical Trial Currently Recruiting Patients With Advanced Cancer

News

The Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center in Arizona recently started a Phase Ib/II clinical trial called NivoPlus (NCT02423954) to test a new investigational immunotherapeutic ... Read more

June 11, 2015June 11, 2015

Simple Test Can Improve Donor Selection for Stem Cell Transplant to Older Blood Cancer Patients

News

Researchers at Abramson Cancer Center (ACC), University of Pennsylvania Perelman School of Medicine in Philadelphia found that measuring the levels of T cells in a blood sample can help to ... Read more

June 2, 2015

ASCO Honors Dr. Jim Allison For His Research in Cancer Immunotherapy

News

The American Society of Clinical Oncology (ASCO) has honored Dr. Jim Allison, chair of Immunology at The University of Texas MD Anderson Cancer Center, with the Science of Oncology Award ... Read more

May 28, 2015

Novel Cell-Squeezing Device Offers New Possibilities for Cell-Based Vaccine Development

News

Researchers at the Massachusetts Institute of Technology (MIT) and its Koch Institute for Integrative Cancer Research recently revealed a new device that offers new possibilities in the field of cell-based ... Read more

May 22, 2015May 22, 2015

Experimental Therapeutic Combination Found to Induce High Response Rate in Advanced Lung Cancer Patients

News

A team of researchers from several institutes and universities in the United States will disclose promising early results on the combination of an anti-cancer agent (MPDL3280A) and standard chemotherapy for ... Read more

May 21, 2015May 26, 2015

Argos’ Cell Immunotherapy Phase 3 Trial for Advanced Renal Cancer is Recruiting Patients

News

Argos Therapeutics Inc., a company focused on personalized immunotherapies for cancer treatment, recently announced that the ongoing pivotal phase 3 ADAPT clinical trial (NCT01582672) of its product AGS-003 for the ... Read more

May 7, 2015May 7, 2015

Silicon Microparticles Found to Increase the Effectiveness of Cancer Vaccines

News

Researchers at the Houston Methodist Research Institute, the Baylor College of Medicine and the University of Texas MD Anderson Cancer Center recently revealed a new method to increase the anti-tumor activity ... Read more

April 17, 2015April 17, 2015

Therapeutic Nanoparticles Found To Induce an Effective Antitumor Immune Response at a Specific Temperature

News

Researchers at the Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center and the Wistar Institute have discovered the exact temperature at which a cancer immunotherapy strategy based on ... Read more

April 15, 2015April 15, 2015

Alliance Between Novartis and Aduro Biotech To Foster New Cancer Immunotherapies

News

Novartis recently announced the establishment of a major multi-year alliance with Aduro Biotech to discover and develop next generation cancer immunotherapies that target a specific signaling pathway involving a molecule called STING (stimulator of ... Read more